Severely contracted bladder following intravesical mitomycin C therapy

Area of Science:

• Urology
• Oncology
• Chemotherapy

Background:

• Superficial bladder tumors often recur, necessitating preventative treatment.
• Intravesical chemotherapy, including mitomycin C, is a common approach for managing these tumors.
• Mitomycin C has demonstrated efficacy but can cause side effects like bladder irritation.

Observation:

• A patient undergoing intravesical mitomycin C chemotherapy developed a severely contracted bladder.
• This complication necessitated a urinary diversion procedure.
• The patient experienced bladder irritation and palmar desquamation, consistent with known mitomycin C side effects.

Findings:

• The case suggests a potential association between intravesical mitomycin C and severe bladder contracture.
• While effective for tumor treatment, this rare complication requires consideration.
• Further investigation into the mechanisms of mitomycin C-induced bladder toxicity is warranted.

Implications:

• Clinicians should be aware of the potential for severe bladder contracture as a rare complication of intravesical mitomycin C.
• Careful patient selection and monitoring may be necessary for individuals receiving this treatment.
• This case highlights the importance of reporting and investigating adverse events in chemotherapy.